Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
Measuring quality of care in the anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) has become more complex, because the introduction of immunosuppressive therapy has resulted in a substantial improvement in survival. Early diagnosis remains a problem, because many patients are...
主要な著者: | Mukhtyar, C, Luqmani, R |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2007
|
類似資料
-
Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
著者:: Mukhtyar, C, 等
出版事項: (2008) -
Eular recommendations for vasculitis
著者:: Luqmani, R, 等
出版事項: (2007) -
Cardiovascular outcomes in ANCA associated vasculitis
著者:: Mukhtyar, C, 等
出版事項: (2008) -
Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
著者:: Mukhtyar, C, 等
出版事項: (2007) -
Cardiovascular involvement in primary systemic vasculitis.
著者:: Mukhtyar, C, 等
出版事項: (2009)